Integrated Pharmacogenomic/Pharmacokinomic Approach to Optimize GBM Therapy

Grant

Date/time Interval

  • November 1, 2011 - April 30, 2013
  • Total Award Amount

  • 91718.00
  • Direct Costs

  • 91718.00
  • Sponsor Award Id

  • Contributor

  • Bredel M.D., Ph.D., Markus   Principal Investigator  
  • Gillespie, George   Investigator  
  • Willey M.D., Ph.D., Christopher   Investigator